Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jinny Min"'
Publikováno v:
HemaSphere, Vol 7, p e4809314 (2023)
Externí odkaz:
https://doaj.org/article/6f5f3bd7029f4f5c9a7effdd5144354d
Autor:
Jinny Min, Stanley Cohan, Enrique Alvarez, Jacob Sloane, J. Theodore Phillips, Anneke van der Walt, Irene Koulinska, Fang Fang, Catherine Miller, Andrew Chan
Publikováno v:
Neurology and Therapy, Vol 8, Iss 1, Pp 109-119 (2019)
Abstract Introduction Delayed-release dimethyl fumarate (DMF) is an effective treatment for multiple sclerosis (MS). Some patients experience gastrointestinal (GI) adverse events (AEs) that may lead to premature DMF discontinuation. This study charac
Externí odkaz:
https://doaj.org/article/8827e22cf120421fa3157e93cce2c959
Publikováno v:
Blood. 140:11441-11442
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c2947e2558ee7dece8c28801eb1eebd
https://doi.org/10.1182/blood-2022-160242
https://doi.org/10.1182/blood-2022-160242
Autor:
Andrew Chan, Irene Koulinska, J. Theodore Phillips, Fang Fang, Jinny Min, Enrique Alvarez, Anneke van der Walt, Jacob A. Sloane, Catherine Miller, Stanley Cohan
Publikováno v:
Neurology and Therapy, Vol 8, Iss 1, Pp 109-119 (2019)
Neurology and Therapy
Min, Jinny; Cohan, Stanley; Alvarez, Enrique; Sloane, Jacob; Phillips, J Theodore; van der Walt, Anneke; Koulinska, Irene; Fang, Fang; Miller, Catherine; Chan, Andrew (2019). Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes. Neurology and therapy, 8(1), pp. 109-119. Springer 10.1007/s40120-019-0127-2
Neurology and Therapy
Min, Jinny; Cohan, Stanley; Alvarez, Enrique; Sloane, Jacob; Phillips, J Theodore; van der Walt, Anneke; Koulinska, Irene; Fang, Fang; Miller, Catherine; Chan, Andrew (2019). Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes. Neurology and therapy, 8(1), pp. 109-119. Springer 10.1007/s40120-019-0127-2
Introduction Delayed-release dimethyl fumarate (DMF) is an effective treatment for multiple sclerosis (MS). Some patients experience gastrointestinal (GI) adverse events (AEs) that may lead to premature DMF discontinuation. This study characterized t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ea86001f88a35562037e1738fff3ee5
https://doi.org/10.1007/s40120-019-0127-2
https://doi.org/10.1007/s40120-019-0127-2
Publikováno v:
Revue Neurologique. 175:S101
Introduction Gastrointestinal (GI) adverse events (AEs) associated with DMF can result in premature treatment discontinuation. Objectives To characterize effective real-world patient education and management strategies at sites initiating treatment w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4df6ce7625ac026580d30adcbfe18184
https://doi.org/10.1016/j.neurol.2019.01.262
https://doi.org/10.1016/j.neurol.2019.01.262
Autor:
Macaulay Okwuokenye, Jinny Min, Anneke van der Walt, Jonathan Calkwood, Jacob A. Sloane, Catherine Taylor, J. Theodore Phillips
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 89:A19.1-A19
IntroductionIn real world comparative effectiveness studies of relapsing-remitting multiple sclerosis (RRMS) patients, treatment with delayed-release dimethyl fumarate (DMF) compared with fingolimod (FTY) for ≤2 years was associated with no statist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68aa5faf1251699d4decc54b6ba8f4af
https://doi.org/10.1136/jnnp-2018-anzan.44
https://doi.org/10.1136/jnnp-2018-anzan.44